Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.
Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru D.
Tong Z, et al. Among authors: guha s.
Oncotarget. 2017 Apr 25;8(17):28696-28710. doi: 10.18632/oncotarget.15645.
Oncotarget. 2017.
PMID: 28404924
Free PMC article.